Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2013, Article ID 651902, 5 pages
http://dx.doi.org/10.1155/2013/651902
Case Report

Successful Use of Cyclophosphamide as an Add-On Therapy for Multiple Myeloma Patients with Acquired Resistance to Bortezomib or Lenalidomide

Hematology & Oncology, Department of Internal Medicine, Iwate Medical University School of Medicine, Morioka, Iwate 020-8505, Japan

Received 25 January 2013; Accepted 3 March 2013

Academic Editors: E. Arellano-Rodrigo, K. Konstantopoulos, M.-C. Kyrtsonis, R. Lowenthal, and Y. Matsukawa

Copyright © 2013 Shigeki Ito et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Shigeki Ito, Tatsuo Oyake, Kazunori Murai, and Yoji Ishida, “Successful Use of Cyclophosphamide as an Add-On Therapy for Multiple Myeloma Patients with Acquired Resistance to Bortezomib or Lenalidomide,” Case Reports in Hematology, vol. 2013, Article ID 651902, 5 pages, 2013. https://doi.org/10.1155/2013/651902.